Date of this Version


Document Type

DNP Project


Postoperative nausea and vomiting (PONV) is the most common side effect of patients receiving anesthesia. These outcomes are seen both shortly after and within 24 hours of a surgical procedure. PONV rates among surgical candidates can be as high as 30%. There are many drug combinations anesthesia providers utilize to prevent PONV, including Reglan, Zofran, Decadron, Scopolamine, Emend, and Propofol to some degree. However, anesthesia providers do not commonly give Haldol to patients intra-operatively, even though it contains both anti-nausea and anti-vomiting properties. The purpose of this paper is to educate anesthesia providers on the benefits of incorporating Haldol in their patient treatment plans to help prevent PONV.